Preparation of Monoclonal Antibody for Brevetoxin 1 and Development of Ic-ELISA and Colloidal Gold Strip to Detect Brevetoxin 1
- PMID: 29419743
- PMCID: PMC5848176
- DOI: 10.3390/toxins10020075
Preparation of Monoclonal Antibody for Brevetoxin 1 and Development of Ic-ELISA and Colloidal Gold Strip to Detect Brevetoxin 1
Abstract
Brevetoxin-1 (BTX-1), a marine toxin mostly produced by the dinoflagellatae Karenia brevis, has caused the death of marine organisms and has had numerous toxicological effects on human health. Hence, it is very necessary to develop a rapid, economical, and reliable immunoassay method for BTX-1 detection. In this study, two kinds of complete antigen were synthesized using the succinic anhydride and isobutyl chloroformate two-step methods. Conjugate BTX-1-OVA was used as an antigen for mice immunization, and BTX-1-BSA for measuring the titer of the produced antibodies. A hybridoma cell line 6C6 stably secreting monoclonal antibody (mAb) against BTX-1 was obtained by fusing SP2/0 myeloma cells with the spleen cells from the immunized mouse. The hybridoma 6C6 was injected into the abdomen of BALB/c mice to obtain ascites, and the anti-BTX-1 mAb was harvested from ascites by precipitation with caprylic acid/ammonium sulfate (CA-AS). The anti-BTX-1 mAb was identified as an IgG1 subtype, and the cross-reactivity results showed that anti-BTX-1 mAb was highly specific to BTX-1 with the affinity of 1.06 × 10⁸ L/mol. The indirect competitive ELISA results indicated that the linear range for BTX-1 detection was 14-263 ng/mL with IC50 of 60 ng/mL, and a detection limit of 14 ng/mL. The average recovery rate from the spiked samples was 88 ± 2% in intra-assay and 89 ± 2% in inter-assay. The limit of detection (LOD) using the colloidal gold strip was 200 ng/mL with high specificity. Therefore, the anti-BTX-1 mAb can be used to detect BTX-1 in shellfish and other related samples.
Keywords: Brevetoxin-1; ELISA; colloidal gold strip; monoclonal antibody.
Conflict of interest statement
All authors declare that they have no conflict of interest statement.
Figures






References
-
- David L.S., Plakas S.M., Said K.R.E., Jester E.L.E., Dickey R.W., Nicholson R.A. Nicholson, A rapid assay for the brevetoxin group of sodium channel activators based on fluorescence monitoring of synaptoneurosomal membrane potential. Toxicon. 2003;42:191–198. doi: 10.1016/S0041-0101(03)00133-8. - DOI - PubMed
-
- Abraham A., Plakasa S.M., Wanga Z., Jestera E.L.E., El Saida K.R., Granadea H.R., Henry H.S., Blumb P.C., Pierce R.H., Dickey R.W. Characterization of polar brevetoxin derivatives isolated from Karenia brevis cultures and natural blooms. Toxicon. 2006;48:104–115. doi: 10.1016/j.toxicon.2006.04.015. - DOI - PubMed
-
- Naar J., Bourdelais A., Tomas C., Kubanek J., Whitney P.L., Flewelling L., Steidinger K., Lancaster J., Baden D.G. A Competitive ELISA to Detect Brevetoxins from Karenia brevis (Formerly Gymnodinium breve) in Seawater, Shellfish, and Mammalian Body Fluid. Environ. Health Perspect. 2002;110:179–185. doi: 10.1289/ehp.02110179. - DOI - PMC - PubMed
-
- Legrand A.M., Litaudon M., Genthon J.N., Bagnis R., Yasumoto T. Isolation and some properties of ciguatoxin. J. Appl. Phycol. 1989;1:183–188. doi: 10.1007/BF00003882. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials